Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT04041310
Phase 1
Active, not recruiting
Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
United States, Belgium, Canada, Italy, Spain, United Kingdom